Epa and Zetia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epa (epa (eicosapentaenoic acid)) and Zetia (ezetimibe). Common drug interactions include allergic cough among females and obesity among males.

The phase IV clinical study analyzes what interactions people have when they take Epa and Zetia. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Epa?

Epa has active ingredients of epa (eicosapentaenoic acid). It is often used in high blood cholesterol. eHealthMe is studying from 623 Epa users. Check the latest studies of Epa.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

On Jul, 12, 2026

17 people who take Epa and Zetia together, and have interactions are studied.

What are the common drug interactions of Epa and Zetia, by gender? *:

female:

Allergic cough
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Back pain
Dental caries
Diarrhoea
Dry skin
Dyspepsia (indigestion)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Enterocolitis viral
Inflammation

male:

Obesity (having too much body fat)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Cardiac ventricular thrombosis (blood clot in ventricle)
Cytomegalovirus enterocolitis (virus infection of intestine and colon)
Drug intolerance (drug sensitivity)
Dry mouth
Hepatic failure (liver failure)
Low cardiac output syndrome (decreased cardiac output)
Lung cancer metastatic (lung cancer spreads to other parts)
Metastases to liver (cancer spreads to liver)

What are the common drug interactions of Epa and Zetia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acute myocardial infarction (acute heart attack)

40-49:

Obesity (having too much body fat)
Allergic cough
Back pain
Dental caries
Diarrhoea
Dry skin
Dyspepsia (indigestion)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Enterocolitis viral
Iron deficiency anaemia

50-59:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

60+:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Blood glucose increased
Inflammation
Low cardiac output syndrome (decreased cardiac output)
Lung cancer metastatic (lung cancer spreads to other parts)
Metastases to liver (cancer spreads to liver)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscular weakness (muscle weakness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 23.53%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 23.53%
Hiv Infection: 3 people, 17.65%
Type 2 Diabetes: 2 people, 11.76%
Insomnia (sleeplessness): 2 people, 11.76%
Dyslipidaemia (abnormal amount of lipids): 2 people, 11.76%
Hepatocellular Carcinoma (liver cancer): 2 people, 11.76%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 11.76%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.88%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Epa and Zetia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously